Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nexgel, Inc. (NXGL)
:NXGL
NXGL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.84 - $5.10
Previous CloseN/A
Volume27.00K
Average Volume (3M)112.36K
Market Cap
$33.10M
Enterprise Value$19.45M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.09
Next Earnings
Mar 26, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding6,790,777
10 Day Avg. Volume67,245
30 Day Avg. Volume112,356
Standard Deviation0.18
R-Squared0.03
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.56
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.59
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit31.42
Enterprise Value/Ebitda-5.98
Forecast
1Y Price Target
$6.00Price Target Upside69.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
NexGel Inc News
PremiumCompany Announcements
NexGel Inc Announces New CFO Amid Strategic GrowthPremiumCompany Announcements
NexGel, Inc. Reports Increased Revenue Amid Ongoing Challenges
PremiumPre-Earnings
Is NXGL a Buy, Before Earnings?---
Bulls Say, Bears Say
Bulls Say
Market PositioningNexGel's market cap is only approximately $14 million, but it has secured agreements with large companies like AbbVie, Haleon, and STADA, showcasing its leadership in hydrogel patch technology.
Revenue GrowthNexGel reported revenue of $2.94M, up 141% year-over-year, exceeding both preliminary revenue guidance and analyst estimates.
Strategic PartnershipsA partnership with Cintas Corporation is expected to accelerate sales through Cintas' expansive distribution network.
Bears Say
Execution RiskThe focus in 2H24 shifts to execution, in our view. We expect revenue to continue to increase and expenses to now decline as initiatives come to fruition, ultimately putting NexGel on a path to positive cash flow and eventually profitability.
Profitability ChallengesNexGel’s gross margin improved to 28%, from 22% in 1Q24, but we note that is due to the Silly George contribution which is associated with more marketing costs unlike NexGel’s contract manufacturing.
Revenue DependencyThe 3Q24 revenue numbers do not include the impact of the Cintas Corporation supply agreement, which can further accelerate sales in 4Q24 and 2025.
---
Ownership Overview
19.94% Insiders
1.55% Mutual Funds
0.68% Other Institutional Investors
77.08% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
NXGL FAQ
What was Nexgel, Inc.’s price range in the past 12 months?
Nexgel, Inc. lowest stock price was $1.84 and its highest was $5.10 in the past 12 months.
What is Nexgel, Inc.’s market cap?
Nexgel, Inc.’s market cap is $33.10M.
When is Nexgel, Inc.’s upcoming earnings report date?
Nexgel, Inc.’s upcoming earnings report date is Mar 26, 2025 which is in 35 days.
How were Nexgel, Inc.’s earnings last quarter?
Nexgel, Inc. released its earnings results on Nov 13, 2024. The company reported -$0.11 earnings per share for the quarter, missing the consensus estimate of -$0.1 by -$0.01.
Is Nexgel, Inc. overvalued?
According to Wall Street analysts Nexgel, Inc.’s price is currently Undervalued.
Does Nexgel, Inc. pay dividends?
Nexgel, Inc. does not currently pay dividends.
What is Nexgel, Inc.’s EPS estimate?
Nexgel, Inc.’s EPS estimate is -0.13.
How many shares outstanding does Nexgel, Inc. have?
Nexgel, Inc. has 6,790,777 shares outstanding.
What happened to Nexgel, Inc.’s price movement after its last earnings report?
Nexgel, Inc. reported an EPS of -$0.11 in its last earnings report, missing expectations of -$0.1. Following the earnings report the stock price went down -3.343%.
Which hedge fund is a major shareholder of Nexgel, Inc.?
Currently, no hedge funds are holding shares in NXGL
---
NexGel Inc Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (69.97% Upside)
$6.00 (69.97% Upside)
Insider Transactions
Bought Shares
Worth $108.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
67.29%
12-Months-Change
Fundamentals
Return on Equity
-67.96%
Trailing 12-Months
Asset Growth
6.28%
Trailing 12-Months
Company Description
Nexgel, Inc.
NexGel Inc is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics.
---
NXGL Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance with record revenue growth, improved gross profit margins, and successful strategic initiatives. However, the company faced increased costs and SG&A expenses, resulting in a net loss. Overall, the positive growth metrics and strategic achievements outweigh the challenges.Read More>---
NXGL Stock 12 Month Forecast
Average Price Target
$6.00
▲(69.97% Upside)
Technical Analysis
Best Analysts Covering NXGL
1 Year
1 Year Success Rate
16/21 ratings generated profit
1 Year Average Return
+31.09%
reiterated a buy rating 27 days ago
Copying Naz Rahman's trades and holding each position for 1 Year would result in 76.19% of your transactions generating a profit, with an average return of +31.09% per trade.
---